Exchange: NYSEMkt·Updated 07:52 AM EDT
PLX logo

PLX Protalix BioTherapeutics Inc.

$2.75
$0.09
(3.38%)
Pre-Market
Prev Close $2.66
EarningsNov 12
Mkt Cap$223.18M
Vol1,400.00

About PLX

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
63

Bullish Sentiment

How do you feel about PLX?

Advertisement|Remove ads.